BRD2 and metabolic syndrome: Other studies have supported the opinion that low FSH levels may be a risk factor for dyslipidemia.[12–14] A study including 2658 Chinese postmenopausal women reported a direct association between FSH and HDL-C and an inverse relationship between TG and LDL-C.[15] Another study did not find decrements in serum cholesterol after eight weeks of anti-FSH antibody treatment.[16] To date, only a few studies have investigated the relationship between FSH levels and serum lipid profiles, and the results have been controversial.